Safe handling of cytotoxics: guideline recommendations
- PMID: 25684994
- PMCID: PMC4324350
- DOI: 10.3747/co.21.2151
Safe handling of cytotoxics: guideline recommendations
Abstract
Background: This evidence-based practice guideline was developed to update and address new issues in the handling of cytotoxics, including the use of oral cytotoxics; the selection and use of personal protective equipment; and treatment in diverse settings, including the home setting.
Methods: The guideline was developed primarily from an adaptation and endorsement of an existing guideline and from three systematic reviews. Before publication, the guideline underwent a series of peer and external reviews to gather feedback. All comments were addressed, and the guideline was amended when required. The guideline applies to health care workers who could come into contact with cytotoxic drugs at any point in the medication circuit. The intended users are hospital administrators, educators, and managers; occupational health and safety services; and pharmacy and health care workers.
Results: The recommendations represent a reasonable and practical set of procedures that the intended users of this guideline should implement to minimize opportunities for accidental exposure. They are not limited to just the point of care; they cover the entire chain of cytotoxics handling from the time such agents enter the institution until they leave in the patient or as waste.
Conclusions: Reducing the likelihood of accidental exposure to cytotoxic agents within the medication circuit is the main objective of this evidenced-based guideline. The recommendations differ slightly from earlier guidelines because of the availability of new evidence.
Keywords: Cytotoxic drugs; cytotoxic drug administration; cytotoxic drug preparation; guidelines; hazardous waste; personal protective equipment.
Figures
References
-
- Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13:502–12. - PubMed
-
- Browman GP, Newman TE, Mohide EA, et al. Progress of clinical oncology guidelines development using the practice guidelines development cycle: the role of practitioner feedback. J Clin Oncol. 1998;16:1226–31. - PubMed
-
- Association paritaire pour la santé et la sécurité du travail du secteur affaires sociales (asstsas), Working Committee on the Safe Handling of Hazardous Drugs. Prevention Guide: Safe Handling of Hazardous Drugs. Montreal, QC: ASSTSAS; 2008. [Free download available at: http://www.irsst.qc.ca/-publication-irsst-guide-de-prevention-manipulati...; cited July 13, 2013]
-
- United States, Department of Health and Human Services, Centers for Disease Control and Prevention (cdc), National Institute for Occupational Health and Safety. Atlanta, GA: CDC; 2014. Workplace Safety & Health Topics: Engineering Controls [Web page]. [Available online at: http://www.cdc.gov/niosh/topics/engcontrols/; cited May 8, 2014]
-
- Service Ontario, e-Laws. Occupational Health and Safety Act. Toronto, ON: Government of Ontario; 2013. Ontario Regulation 67/93: Health Care and Residential Facilities [Web page]. [Available at: http://www.e-laws.gov.on.ca/html/regs/english/elaws_regs_930067_e.htm; cited May 8, 2014]
LinkOut - more resources
Full Text Sources
